Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/11/928   
Active ingredient: Cysteamine
Indication: Treatment of cystic fibrosis
Sponsor: NovaBiotics Ltd
Cruickshank Building, Craibstone, Aberdeen AB21 9TR, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/12/2011 Orphan designation EMA/OD/046/11 (2011)9412 of 09/12/2011